Login

Financial Snapshot

Revenue
TTM
$12.56B
Gross Margin
TTM
5.77%
Net Income
TTM
-$66.39M
Current Assets
2025 Q4
Current Liabilities
2025 Q4
Current Ratio
2025 Q4
108.76%
Total Assets
2025 Q4
Total Liabilities
2025 Q4
Book Value
2025 Q4
30.66M
Cash
2025 Q4
P/E
Last 4 Quarters
N/A
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $46.45 Million

About 111 Inc

111, Inc. Is a holding company, which engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2018-09-12. The firm mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The firm also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The firm mainly conducts its business in the domestic market.

Industry: Retail-Drug Stores and Proprietary Stores Peers: Ridgetech Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support